Glow-in-the-dark dye could help surgeons spot hidden cancer
NCT ID NCT07278986
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether a dye called CYTALUX (pafolacianine) can make endometrial cancer cells glow under a special camera during surgery. The goal is to help surgeons find and remove all cancer. Ten adults with endometrial cancer who are already scheduled for surgery will receive one dose of the dye before their operation. The study focuses on safety and how well the dye lights up cancer tissue.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTALUX (PAFOLACIANINE) INJECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Abramson Cancer Center at Penn Medicine
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
University of Pennsylvania Gynecologic Oncology Department
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- What raises endometrial cancer risk in black women? a study digs in
- Can immunotherapy plus hormones spare the womb in early endometrial cancer?
- Can a new drug tackle Hard-to-Treat gynecologic cancers?
- Can a pill restore the Body's tumor suppressor to fight multiple cancers?
- Could gentle yoga and breathing ease Cancer's lingering toll?